In8Bio Inc (INAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | INAB | AMGN | REGN | VRTX | BMY |
| Company | In8Bio Inc | Amgen Inc | Regeneron Pharmaceuticals | Vertex Pharmaceutic | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 0.5322 | 331.95 | 1,179.20 | 495.67 | 49.72 |
| High | 0.5490 | 335.66 | 1,191.33 | 500.25 | 50.24 |
| Low | 0.5150 | 330.30 | 1,170.84 | 492.29 | 49.68 |
| Last | 0.5264 | 333.83 | 1,184.69 | 495.89 | 49.95 |
| Change | +0.0072 | +2.82 | +5.76 | +2.54 | +0.23 |
| % Change | +1.39% | +0.85% | +0.49% | +0.51% | +0.46% |
| Volume | 59,400 | 2,173,500 | 405,300 | 1,809,600 | 9,594,700 |
| 20-Day Average Volume | 218,770 | 1,939,180 | 443,830 | 1,175,450 | 11,541,060 |
| Previous Close | 0.5192 | 331.01 | 1,178.93 | 493.35 | 49.72 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.6021 | 325.70 | 1,158.30 | 478.45 | 48.28 |
| 20-Day Raw Stochastic | 10.56% | 93.70% | 83.55% | 89.67% | 92.79% |
| 20-Day Relative Strength | 35.77% | 57.39% | 65.34% | 59.44% | 62.87% |
| Weighted Alpha | -69.36 | +30.86 | +48.32 | +41.96 | -12.66 |
| Today's Opinion | 100% Sell | 96% Buy | 100% Buy | 80% Buy | 56% Buy |
| Previous Opinion | 100% Sell | 88% Buy | 100% Buy | 80% Buy | 56% Buy |
| Last Month's Opinion | 88% Sell | 100% Buy | 100% Buy | 100% Buy | 8% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -1.61% since 08/23/24 | +1.53% since 08/23/24 | -1.20% since 08/23/24 | +3.04% since 08/23/24 | +3.82% since 08/23/24 |
| Low | 0.5000 on 08/29/24 | 325.39 on 08/28/24 | 1,170.84 on 08/30/24 | 476.38 on 08/27/24 | 47.81 on 08/27/24 |
| High | 0.5881 on 08/26/24 | 335.66 on 08/30/24 | 1,211.20 on 08/27/24 | 500.25 on 08/30/24 | 50.24 on 08/30/24 |
| 1-Month | |||||
| %Chg | -36.49% since 07/30/24 | +0.17% since 07/30/24 | +9.92% since 07/30/24 | -1.34% since 07/30/24 | +1.83% since 07/30/24 |
| Low | 0.5000 on 08/29/24 | 306.59 on 08/07/24 | 1,041.85 on 08/01/24 | 458.04 on 08/13/24 | 46.22 on 08/08/24 |
| High | 0.8587 on 07/31/24 | 340.89 on 08/01/24 | 1,211.20 on 08/27/24 | 510.64 on 08/01/24 | 50.24 on 08/30/24 |
| 3-Month | |||||
| %Chg | -48.89% since 05/30/24 | +10.91% since 05/30/24 | +22.14% since 05/30/24 | +11.93% since 05/30/24 | +24.10% since 05/30/24 |
| Low | 0.5000 on 08/29/24 | 295.30 on 06/13/24 | 967.43 on 05/31/24 | 443.47 on 05/31/24 | 39.35 on 07/05/24 |
| High | 1.7400 on 06/13/24 | 346.85 on 07/25/24 | 1,211.20 on 08/27/24 | 510.64 on 08/01/24 | 51.19 on 07/29/24 |
| 6-Month | |||||
| %Chg | -52.58% since 02/29/24 | +21.91% since 02/29/24 | +22.63% since 02/29/24 | +17.86% since 02/29/24 | -1.58% since 02/29/24 |
| Low | 0.5000 on 08/29/24 | 260.68 on 04/19/24 | 875.22 on 04/26/24 | 391.01 on 04/18/24 | 39.35 on 07/05/24 |
| High | 1.7400 on 06/13/24 | 346.85 on 07/25/24 | 1,211.20 on 08/27/24 | 510.64 on 08/01/24 | 55.03 on 03/13/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 23,227 | 179,078,080 | 130,536,232 | 127,965,912 | 101,253,648 |
| Shares Outstanding, K | 44,124 | 536,435 | 110,186 | 258,053 | 2,027,100 |
| Annual Sales | 0 | 28,190,000,000 | 13,117,200,000 | 9,869,200,000 | 45,006,000,000 |
| Annual Net Income | -30,010,000 | 6,717,000,000 | 3,953,600,000 | 3,619,600,000 | 8,025,000,000 |
| Last Quarter Sales | 0 | 8,388,000,000 | 3,547,100,000 | 2,645,600,000 | 12,201,000,000 |
| Last Quarter Net Income | -8,630,000 | 746,000,000 | 1,432,300,000 | -3,593,600,000 | 1,680,000,000 |
| 60-Month Beta | 0.06 | 0.58 | 0.13 | 0.39 | 0.44 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.19 on 08/08/24 | 4.97 on 08/06/24 | 11.56 on 08/01/24 | -12.83 on 08/01/24 | 2.07 on 07/26/24 |
| Latest Earnings Date | 08/08/24 | 08/06/24 | 08/01/24 | 08/01/24 | 10/24/24 |
| Most Recent Dividend | N/A | 2.250 on 08/16/24 | N/A | N/A | 0.600 on 07/05/24 |
| Next Ex-Dividends Date | N/A | 08/16/24 | N/A | N/A | 07/05/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 17.80 | 30.69 | 0.00 | 36.29 |